ScoreWhy is Anuh Pharma Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 13.54% and Operating profit at 11.42% over the last 5 years
2
Flat results in Dec 25
- ROCE(HY) Lowest at 15.90%
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 2.15 cr
3
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Anuh Pharma for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Anuh Pharma
1.08%
0.03
38.62%
Sensex
1.0%
0.08
12.13%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.54%
EBIT Growth (5y)
11.42%
EBIT to Interest (avg)
44.09
Debt to EBITDA (avg)
0.36
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
2.06
Tax Ratio
25.29%
Dividend Payout Ratio
15.87%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
19.97%
ROE (avg)
14.83%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
33
Price to Book Value
2.35
EV to EBIT
16.26
EV to EBITDA
13.12
EV to Capital Employed
2.41
EV to Sales
0.99
PEG Ratio
NA
Dividend Yield
1.95%
ROCE (Latest)
14.43%
ROE (Latest)
12.79%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET SALES(9M)
At Rs 569.54 cr has Grown at 22.91%
PBT LESS OI(Q)
At Rs 13.72 cr has Grown at 22.7% (vs previous 4Q average
PAT(Q)
At Rs 13.45 cr has Grown at 39.0% (vs previous 4Q average
EPS(Q)
Highest at Rs 1.34
-4What is not working for the Company
ROCE(HY)
Lowest at 15.90%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 2.15 cr
Loading Valuation Snapshot...
Here's what is working for Anuh Pharma
Net Sales - Nine Monthly
At Rs 569.54 cr has Grown at 22.91%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 13.72 cr has Grown at 22.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 11.18 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 13.45 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 13.45 cr has Grown at 39.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 9.68 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 1.34
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Anuh Pharma
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 2.15 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
